|
ABOUT COMPANY
NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. The company is headquartered in Shelton, Connecticut.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 39415500
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.818
Dividend Date: 2019-09-24
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -7963771
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|